Corrigendum to: Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people

European Heart Journal

25 May 2020
Organised by: Logo
ESC Journals CARDIOVASCULAR PHARMACOLOGY Research Methodology PREVENTIVE CARDIOLOGY Risk Factors and Prevention Pharmacology and Pharmacotherapy

ESC 365 is supported by